← All trials
NCT04248868
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 23, 2020
- Primary completion
- Jul 1, 2022
- Completion date
- Sep 1, 2022
- First posted
- Jan 30, 2020
- Last posted
- Sep 23, 2020
- Enrollment
- 125
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Thrombolex, Inc.Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Thrombolex, Inc.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.